Claim Missing Document
Check
Articles

Found 2 Documents
Search

Type 1 Diabetes Mellitus in Children: Diagnosis and Management Rike Delya Rizkina; Ananda Rizkia; Donna Diva Widyantari; Ghina Syafinatunnajah; Grandis Cristagalli; Irsyadina Hasana Bharata; Izza Mufida; Yoga Pamungkas Susani
Jurnal Biologi Tropis Vol. 23 No. 1 (2023): Special Issue
Publisher : Biology Education Study Program, Faculty of Teacher Training and Education, University of Mataram, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/jbt.v23i4b.5820

Abstract

Diabetes is a chronic metabolic disease characterized by increased blood sugar levels over time. This disease is caused by the presence of impaired insulin secretion, impaired insulin action, or both. The method used in writing this article is literature study. The literature study was carried out by searching published articles regarding the diagnosis and management of type 1 diabetes mellitus (T1DM) in children. Diagnosis is determined based on typical symptoms including polydipsia, polyuria, and decline body weight accompanied by blood sugar measurements. Components of managing T1DM (Type 1 Diabetes Mellitus) including (1) education; (2) insulin administration; (3) diet management; (4) physical activity; (5) self-monitoring; and (6) psychosocial therapy. Management of diabetes is necessary to achieve metabolic control optimally, preventing acute complications, microvascular or macrovascular complications, as well to improve the psychological aspects of patients and families.
Diagnosis dan Tatalaksana Guillain Barré Syndrome Grandis Cristagalli; Herpan Syafii Harahap; Safat Wahyudi; Aulia Dwi Hendriani; Izza Mufida; Muhammad Sutan Maulana; Rike Delya Rizqina
Lombok Medical Journal Vol. 3 No. 1 (2024): Lombok Medical Journal Volume 3 Nomor 1
Publisher : Faculty of Medicine, Universitas Mataram

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/lmj.v3i1.2886

Abstract

Guillain-Barré Syndrome or GBS is one of the emergency conditions of neurology. Currently, its incidence is relatively low and rare, with a rate of 0.81 to 1.89 of 100,000 people in a year. Guillain-Barré Syndrome or GBS, also known as acute inflammatory demyelinating polyradiculoneuropathy, is a collection of clinical symptoms caused by an acute inflammatory process that attacks the nervous system. The dominant pathogen that causes Guillain-Barré Syndrome (GBS) is Campylobacter jejuni (C. jejuni). Infection with the pathogen Campylobacter jejuni can trigger an immune and humoral autoimmune response that results in nerve dysfunction and the emergence of GBS symptoms. The clinical course of GBS can be divided into several phases, including the progressive phase, plateau phase, and recovery phase. In cases of GBS, it is possible that these factors are involved in the onset of the disease. Some risk factors associated with GBS include viral infections such as Zika virus, influenza virus, and measles-rubella virus. The diagnosis of GBS includes the main symptoms, additional symptoms, cerebrospinal fluid examination, electrophysiological tests, and the exclusion of other diagnoses. The main symptoms include progressive weakness in the extremities accompanied by or without ataxia and areflexia or hyporeflexia in the tendons. The management that can be done includes supportive therapy through the respiratory system. Another treatment option is immunotherapy, with the goal of accelerating disease recovery and reducing the severity of GBS through the immune system.